|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM374459371 |
003 |
DE-627 |
005 |
20241010232213.0 |
007 |
cr uuu---uuuuu |
008 |
240704s2024 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/adma.202404784
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1563.xml
|
035 |
|
|
|a (DE-627)NLM374459371
|
035 |
|
|
|a (NLM)38958110
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Schneider, Paul
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Multicompartment Polyion Complex Micelles Based on Triblock Polypept(o)ides Mediate Efficient siRNA Delivery to Cancer-Associated Fibroblasts for Antistromal Therapy of Hepatocellular Carcinoma
|
264 |
|
1 |
|c 2024
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 10.10.2024
|
500 |
|
|
|a Date Revised 10.10.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2024 The Author(s). Advanced Materials published by Wiley‐VCH GmbH.
|
520 |
|
|
|a Hepatocellular carcinoma (HCC) is the most frequent type of primary liver cancer and the third leading cause for cancer-related death worldwide. The tumor is difficult-to-treat due to its inherent resistance to chemotherapy. Antistromal therapy is a novel therapeutic approach, targeting cancer-associated fibroblasts (CAF) in the tumor microenvironment. CAF-derived microfibrillar-associated protein 5 (MFAP-5) is identified as a novel target for antistromal therapy of HCC with high translational relevance. Biocompatible polypept(o)ide-based polyion complex micelles (PICMs) constructed with a triblock copolymer composed of a cationic poly(l-lysine) complexing anti-MFAP-5 siRNA (siMFAP-5) via electrostatic interaction, a poly(γ-benzyl-l-glutamate) block loading cationic amphiphilic drug desloratatine (DES) via π-π interaction as endosomal escape enhancer and polysarcosine poly(N-methylglycine) for introducing stealth properties, are generated for siRNA delivery. Intravenous injection of siMFAP-5/DES PICMs significantly reduces the hepatic tumor burden in a syngeneic implantation model of HCC, with a superior MFAP-5 knockdown effect over siMFAP-5 PICMs or lipid nanoparticles. Transcriptome and histological analysis reveal that MFAP-5 knockdown inhibited CAF-related tumor vascularization, suggesting the anti-angiogenic effect of RNA interference therapy. In conclusion, multicompartment PICMs combining siMFAP-5 and DES in a single polypept(o)ide micelle induce a specific knockdown of MFAP-5 and demonstrate a potent antitumor efficacy (80% reduced tumor burden vs untreated control) in a clinically relevant HCC model
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a desloratadine
|
650 |
|
4 |
|a endosomal escape
|
650 |
|
4 |
|a hepatocellular carcinoma
|
650 |
|
4 |
|a polyion complex micelles
|
650 |
|
4 |
|a polypept(o)ides
|
650 |
|
4 |
|a siRNA co‐delivery
|
650 |
|
7 |
|a RNA, Small Interfering
|2 NLM
|
650 |
|
7 |
|a Micelles
|2 NLM
|
700 |
1 |
|
|a Zhang, Heyang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Simic, Leon
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Dai, Zhuqing
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Schrörs, Barbara
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Akilli-Öztürk, Özlem
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lin, Jian
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Durak, Feyza
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Schunke, Jenny
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Bolduan, Vanessa
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Bogaert, Bram
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Schwiertz, David
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Schäfer, Gabriela
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Bros, Matthias
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Grabbe, Stephan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Schattenberg, Jörn Markus
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Raemdonck, Koen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Koynov, Kaloian
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Diken, Mustafa
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kaps, Leonard
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Barz, Matthias
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 36(2024), 41 vom: 05. Okt., Seite e2404784
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
773 |
1 |
8 |
|g volume:36
|g year:2024
|g number:41
|g day:05
|g month:10
|g pages:e2404784
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202404784
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 36
|j 2024
|e 41
|b 05
|c 10
|h e2404784
|